Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.23.1
Segment Information
6 Months Ended
Feb. 28, 2023
Segment Information  
Segment Information

13.  Segment Information

 

The Company’s operations involve the development and usage, including licensing, of its proprietary DehydraTECH Technology. Lexaria is centrally managed and its chief operating decision makers, being the President and the CEO, use the consolidated and other financial information, supplemented by revenue information by category of alternative health consumer products and technology licensing, to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property and B2B Products. Licensing revenues are significantly concentrated on one licensee.

 

Six Months Ended February 28, 2023

 

IP Licensing

 

 

B2B

 

 

Corporate

 

 

Consolidated Total

 

Revenue

 

$ 80,310

 

 

$ 30,300

 

 

$ 25,881

 

 

$ 136,491

 

Cost of goods sold

 

 

-

 

 

 

(18,753 )

 

 

-

 

 

 

(18,753 )

Operating expenses

 

 

(45,758 )

 

 

(183,030 )

 

 

(2,968,894 )

 

 

(3,197,682 )

Segment income (loss)

 

$ 34,552

 

 

$ (171,483 )

 

$ (2,943,013 )

 

$ (3,079,944 )

Total assets

 

$ 114,546

 

 

$ 72,929

 

 

$ 4,667,504

 

 

$ 4,854,979

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended February 28, 2022

 

IP Licensing

 

 

B2B

 

 

Corporate

 

 

Consolidated Total

 

Revenue

 

$ 16,160

 

 

$ 17,512

 

 

$ 10,858

 

 

$ 44,530

 

Cost of goods sold

 

 

-

 

 

 

(11,957 )

 

 

-

 

 

 

(11,957 )

Operating expenses

 

 

(1,367,712 )

 

 

(190,611 )

 

 

(1,926,406 )

 

 

(3,484,729 )

Segment loss

 

$ (1,351,552 )

 

$ (185,056 )

 

$ (1,915,548 )

 

$ (3,452,156 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$ 939,790

 

 

$ 87,291

 

 

$ 10,387,483

 

 

$ 11,414,564

 

Capital Asset by Region                           

Six Months Ended February 28, 2023

 

Cost

US

 

 

Addition US

 

 

Net Balance

US

 

 

Cost

Canada

 

 

Addition Canada

 

 

Net Balance Canada

 

 

Total Net Balance

 

 Leasehold Improvements

 

$ -

 

 

$ -

 

 

$ -

 

 

$ 259,981

 

 

$ -

 

 

$ 38,277

 

 

$ 38,277

 

 Computers

 

 

-

 

 

 

-

 

 

 

-

 

 

 

70,781

 

 

 

-

 

 

 

6,991

 

 

 

6,991

 

 Furniture & Fixtures

 

 

-

 

 

 

-

 

 

 

-

 

 

 

31,126

 

 

 

-

 

 

 

5,079

 

 

 

5,079

 

 Lab Equipment

 

 

140,487

 

 

 

33,748

 

 

 

127,880

 

 

 

193,185

 

 

 

-

 

 

 

123,194

 

 

 

251,074

 

 

 

$ 140,487

 

 

$ 33,748

 

 

$ 127,880

 

 

$ 555,073

 

 

$ -

 

 

$ 173,541

 

 

$ 301,421

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Asset by Region                  

Year Ended August 31, 2022

 

Cost

US

 

 

Addition

US

 

 

Net Balance

US

 

 

Cost

Canada

 

 

Addition Canada

 

 

Net Balance Canada

 

 

Total Net Balance

 

 Leasehold Improvements

 

$ -

 

 

$ -

 

 

$ -

 

 

$ 259,981

 

 

$ -

 

 

$ 65,296

 

 

$ 65,296

 

 Computers

 

 

-

 

 

 

-

 

 

 

-

 

 

 

63,964

 

 

 

6,817

 

 

 

9,357

 

 

 

9,357

 

 Furniture & Fixtures

 

 

-

 

 

 

-

 

 

 

-

 

 

 

31,126

 

 

 

-

 

 

 

8,289

 

 

 

8,289

 

 Lab Equipment

 

 

98,050

 

 

 

42,375

 

 

 

100,031

 

 

 

193,185

 

 

 

-

 

 

 

132,533

 

 

 

232,563

 

 

 

$ 98,050

 

 

$ 42,375

 

 

$ 100,031

 

 

$ 548,256

 

 

$ 6,817

 

 

$ 215,475

 

 

$ 315,505